C81 Category · further specificity required Hodgkin lymphoma
ICD-10-CM C81 identifies “Hodgkin lymphoma” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 2: Neoplasms
Code-level instructions
Excludes 11
personal history of Hodgkin lymphoma (Z85.71)
Inherited instructions
Chapters 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
C81-C96 · Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)
More specific codes
C81.0Nodular lymphocyte predominant Hodgkin lymphomaCategory · further specificity requiredC81.1Nodular sclerosis Hodgkin lymphomaCategory · further specificity requiredC81.2Mixed cellularity Hodgkin lymphomaCategory · further specificity requiredC81.3Lymphocyte depleted Hodgkin lymphomaCategory · further specificity requiredC81.4Lymphocyte-rich Hodgkin lymphomaCategory · further specificity requiredC81.7Other Hodgkin lymphomaCategory · further specificity requiredC81.9Hodgkin lymphoma, unspecifiedCategory · further specificity requiredOfficial index references
References from other codes (6)
Excludes 1 · Hodgkin lymphoma (C81.-)
Excludes 1 · malignant neoplasm of lymphoid, hematopoietic and related tissue (C81-C96)
Excludes 1 · malignant neoplasm of lymph nodes, specified as primary (C81-C86, C88, C96.-)
Code first · , if applicable, any current malignant neoplasm (C00-C75, C81-C96)
Inclusion terms · Conditions classifiable to C81-C90, C96.-
Inclusion terms · Conditions classifiable to C81
History
Code history
No recorded change since first observation
Effective from
- First observed
Hodgkin lymphoma
Category — select a more specific code
CDC/NCHS · FY2016All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.